Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.31%)
As of: Nov 16, 2026 · 12:20 PM EST

Elite Pharmaceuticals (ELTP) Net Margin (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) reported Net Margin of 43.21% for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 5.48 percentage points from 37.73% a year earlier and up 24.94 percentage points from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Net Margin (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Elite Pharmaceuticals' Net Margin came in at 41.64%, up 30.31 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at 30.14%, up 35.28 percentage points from FY2025.

  • Net Margin has a five-year change of +10.09 percentage points (FY2021 to FY2026).
  • By fiscal year, Net Margin came in at -5.13% in FY2025 (-40.65 pp), 35.51% in FY2024 (+25.08 pp), 10.43% in FY2023 (-17.15 pp) and 27.58% in FY2022 (+7.53 pp).
  • Five-year quarterly Net Margin spans a low of -75.83% in fiscal Q3 2025 and a high of 105.49% in fiscal Q2 2024.
  • Year over year, Net Margin gained in five of the last eight quarters, with an average year-over-year change of +24.72 percentage points.
  • The high point for year-over-year Net Margin in five years was fiscal Q3 2026 (a gain of 134.69 percentage points); the low point was fiscal Q2 2025 (a drop of 163.94 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at 18.27% (Q1 2027), 45.31% (Q4 2026) and 58.86% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,291.18 Bn 1,264.79 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 686.56 Bn 606.42 Bn 17.30 Bn 0.83%
3 AbbVie 525.29 Bn 493.30 Bn 13.12 Bn 24.24%
4 Merck 362.24 Bn 325.18 Bn 13.19 Bn 28.01%
5 Novartis Ag 313.66 Bn 286.90 Bn - -
6 Astrazeneca 286.68 Bn 260.20 Bn 13.26 Bn 20.69%
7 Amgen 253.44 Bn 205.10 Bn 7.58 Bn 37.28%
8 Gilead Sciences 210.62 Bn 185.73 Bn 6.73 Bn 29.27%
9 Pfizer 165.41 Bn 112.77 Bn 12.56 Bn 19.55%
10 Elite Pharmaceuticals 397.46 Mn 270.87 Mn 15.99 Mn 43.21%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 43.21%
Jun 30, 2026 18.27%
Mar 31, 2026 45.31%
Dec 31, 2025 58.86%
Sep 30, 2025 37.73%
Jun 30, 2025 -14.63%
Mar 31, 2025 53.12%
Dec 31, 2024 -75.83%
Sep 30, 2024 -58.45%
Jun 30, 2024 3.27%
Mar 31, 2024 18.53%
Dec 31, 2023 4.55%
Sep 30, 2023 105.49%
Jun 30, 2023 12.71%
Mar 31, 2023 -20.72%
Dec 31, 2022 36.14%
Sep 30, 2022 25.66%
Jun 30, 2022 3.99%
Mar 31, 2022 31.66%
Dec 31, 2021 25.44%
API Access

Elite Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEY